P.130 Bumetanide versus placebo for core symptoms of autism spectrum disorder at 91 days (BAMBI): a single-centre, double-blinded, patient-randomized, placebo-controlled, phase-2-trial

Saved in:
Bibliographic Details
Published in:European neuropsychopharmacology 2020-11, Vol.40, p.S80-S81
Main Authors: Sprengers, J., Van Andel, D., Zuithoff, N., Keijzer-Veen, M., Annelien, S., Scheepers, F., Lilien, M., Oranje, B., Bruining, H.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0924-977X
1873-7862
DOI:10.1016/j.euroneuro.2020.09.108